deltatrials
Unknown PHASE2/PHASE3 NCT00868972

Renal Stenting With Distal Atheroembolic Protection

Percutaneous Renal Stenting in Renovascular Disease With or Without Distal Atheroembolic Protection

Sponsor: Universita di Verona

Conditions Renal Artery Obstruction Renovascular Hypertension
Interventions Distal embolic protection Percutaneous renal stenting intervention
Updated 5 times since 2017 Last updated: Jan 22, 2010 Started: Mar 31, 2009 Primary completion: Mar 31, 2011 Completion: Sep 30, 2011

A PHASE2/PHASE3 clinical study on Renal Artery Obstruction and Renovascular Hypertension, this trial is ongoing. The trial is conducted by Universita di Verona and has accumulated 5 data snapshots since 2009. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2/PHASE3

    Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2_PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE2_PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE2_PHASE3

    First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Universita di Verona
Data source: Universita di Verona

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Verona, Italy